The 10th Annual New York CISO & Technology Leadership Summit, held on June 9, 2026, gathered top C-level tech leaders to discuss the evolving role of technology executives amid AI disruption and rising security demands. Key topics included leading like a CEO, AI-native security, and balancing innovation with resilience. The event featured expert panels from major firms like Microsoft, Pfizer, and Bank of America, emphasizing the strategic importance of cybersecurity and visionary leadership in shaping enterprise futures. This summit reflects the growing need for authentic, forward-thinking leaders in technology as businesses prepare for 2030 and beyond.
Pfizer reported that its obesity drug berobenatide achieved a 15.9% weight loss in a Phase 2b study without placebo adjustment. The pivotal Phase 3 trial for berobenatide is now open for enrollment, aiming to strengthen Pfizer's position in obesity t...
The alcohol use disorder (AUD) market is projected to expand at a 12.1% compound annual growth rate (CAGR) from 2026 to 2036, driven by unmet clinical needs and the development of novel therapies targeting new mechanisms like the 5-HT3 pathway and NO...
The Pacer US Cash Cows 100 ETF (COWZ), which invests in Russell 1000 companies with the highest free cash flow yields, is seeing its strategy tested as sectors like Energy and Pharma increase capital expenditures and payout ratios. Rising capex in En...
Pfizer reported positive mid-stage trial results for berobenatide, a potential first GLP-1 obesity therapy with monthly dosing, planning up to 10 Phase 3 trials this year. McDonald's is piloting ArchIQ, an AI-powered drive-thru system, automating 90%...
This monthly series highlights five large-cap, dividend-paying stocks trading at significant discounts compared to their historical norms, selected from over 7,500 U.S.-listed companies. The primary list offers an average yield of 4.2%, with two addi...
